Table 1 Patient characteristics
From: Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]
| Â | Placebo starter | GBP starter | Â | Â |
|---|---|---|---|---|
| Â | Â | Â | Excluded from analysis | Â |
| Â | Â | Â | Placebo starter | GBP starter |
| Â | N = 24 | N = 22 | N = 5 | N = 7 |
Sex (F/M) | 21/4 | 18/4 | 3/2 | 6/1 |
Age in years | 42 (± 13) | 47 (± 14) | 40 (± 11) | 43 (± 11) |
Duration in months | 43 (± 36) | 44 (± 21) | 83 (± 39) | 45 (± 30) |
VAS0 | 64.2 (± 16) | 62.5 (± 18) | 62 (± 10) | 67 (± 12) |
VAS2 | 67 (± 20) | 64(± 21) |  |  |
Upper extremity in pain | 3R 8L 3RL = 14 | 8R 7L 4RL = 18 | 2R 0L 1RL | 2R 4L 0RL |
Lower extremity in pain | 2R 7L 4RL = 13 | 3R 3L 0RL = 6 | 2R 1L 0RL | 1R 1L 1RL |